NCT03035708View on ClinicalTrials.gov

Human Laboratory Study of Varenicline for Alcohol Use Disorder

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

July 1, 2018

Study Completion Date

July 7, 2018

Conditions
Alcohol Use Disorder
Interventions
DRUG

Varenicline

1 mg BID

DRUG

Placebo oral capsule

1 mg BID

Trial Locations (2)

06511

Yale University School of Medicine, New Haven

02912

Brown University, Providence

All Listed Sponsors
lead

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

NCT03035708 - Human Laboratory Study of Varenicline for Alcohol Use Disorder | Biotech Hunter | Biotech Hunter